Last update 15 Nov 2025

TAVO-103

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
TAVO103, TAVO103A
Target
IL-1β
Action
modulators
Mechanism
IL-1β modulators(Interleukin-1 beta modulators), Immunomodulators
Therapeutic Areas
Immune System DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
InflammationDiabetes ComplicationsGout+ [1]
Inactive Indication-
Originator Organization
Tavotek Biotherapeutics Co. Ltd.Tavotek Biotherapeutics Co. Ltd.
Active Organization
Tavotek Biotherapeutics Co. Ltd.Tavotek Biotherapeutics Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with TAVO-103
NCT05313152
/ CompletedPhase 1
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAVO103A in Adult Healthy Subjects
100 Clinical Results associated with TAVO-103
Login to view more data
100 Translational Medicine associated with TAVO-103
Login to view more data
100 Patents (Medical) associated with TAVO-103
Login to view more data
100 Deals associated with TAVO-103
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
InflammationPhase 1
United States
Tavotek Biotherapeutics Co. Ltd.Tavotek Biotherapeutics Co. Ltd.
28 Oct 2022
Diabetes ComplicationsPhase 1
United States
Tavotek Biotherapeutics Co. Ltd.Tavotek Biotherapeutics Co. Ltd.
05 Apr 2022
GoutPhase 1
United States
Tavotek Biotherapeutics Co. Ltd.Tavotek Biotherapeutics Co. Ltd.
05 Apr 2022
Rheumatoid ArthritisPhase 1
United States
Tavotek Biotherapeutics Co. Ltd.Tavotek Biotherapeutics Co. Ltd.
05 Apr 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free